The impact of primary Sjogren's syndrome on pregnancy outcome: Our series and review of the literature

Autoimmunity Reviews

Volumn 13, Issue 2, 2014, Pages 103-107

  De Carolis, Sara ^a   Salvi, Silvia ^a   Botta, Angela ^a   Garofalo, Serafina ^a   Garufi, Cristina ^b   Ferrazzani, Sergio ^a   De Carolis, Maria Pia ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Autoimmune disease; Perinatal outcome; Pregnancy; Sjogren's syndrome

Indexed keywords

ACETYLSALICYLIC ACID; ANTIMALARIAL AGENT; BETAMETHASONE; STEROID;

ADULT; ATRIOVENTRICULAR BLOCK; CESAREAN SECTION; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE DURATION; DRUG MEGADOSE; FEMALE; FETUS WASTAGE; HEALTH STATUS; HUMAN; LOW BIRTH WEIGHT; LOW DRUG DOSE; MATERNAL AGE; MEDICAL RECORD REVIEW; PREGNANCY OUTCOME; PREMATURE LABOR; PROGENY; RETROSPECTIVE STUDY; REVIEW; SJOEGREN SYNDROME; SPONTANEOUS ABORTION;

AUTOIMMUNE DISEASE; PERINATAL OUTCOME; PREGNANCY; SJOGREN'S SYNDROME;

ADULT; AUTOANTIBODIES; CASE-CONTROL STUDIES; FEMALE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; RETROSPECTIVE STUDIES; SJOGREN'S SYNDROME;

EID: 84887991522     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2013.09.003     Document Type: Review

References (37)

1. Tincani A., Andreoli L., Cavazzana I., Doria A., Favero M., Fenini M.G., et al. Novel aspects of Sjögren's syndrome in 2012. BMC Med 2013, 11:93.
2. Mavragani C.P., Moutsopoulos H.M. The geoepidemiology of Sjögren's syndrome. Autoimmun Rev 2010, 9:A305-A310.
3. Frassi M., Brucato A., Cavazzana I., Franceschini F., Faden D., Motta M., et al. Neonatal lupus: clinical features and risk of congenital cardiac heart block in newborns from mothers with anti Ro/SSA antibodies. Reumatismo 2001, 53:298-304.
4. Buyon J.P., Clancy R.M. Maternal autoantibodies and congenital heart block: mediators, markers and therapeutic approach. Semin Arthritis Rheum 2003, 33:140-154.
5. Costedoat-Chalumeau N., Georgin-Lavialle S., Amoura Z., Piette J.C. Anti-SSA/Ro and anti-SSB/La antibody-mediated congenital heart block. Lupus 2005, 14:660-664.
6. De Carolis S., Botta A., Grimolizzi F., Garofalo S., Fatigante G., Martino C., et al. Lupus eritematoso sistemico e gravidanza. Aggiornamento Medico 2005, 2:29.
7. Gordon P.A. Congenital heart block: clinical features and therapeutic approaches. Lupus 2007, 168:642-646.
8. Brucato A., Franceschini F., Gasparini M., De Juli E., Ferraro G., Quinzanini M., et al. Isolated congenital complete heart block: longterm outcome of mothers, maternal antibody specificity and immunogenetic background. J Rheumatol 1995, 22:533-540.
9. Miranda-Caroes M.E., Askanase A.D., Clancy R.M., Di Donato F., Chou T.M., Libera M.R., et al. Anti-SSA/Ro and anti-SSB/La autoantibodies bind the surface of apoptotic fetal cardiocytes and promote secretion of TNF-alpha by macrophages. J Immunol 2000, 165:5345-5351.
10. Friedman D.M., Duncanson L.J., Glickstein J., Buyon J.P. A review of congenital heart block. Images Paediatr Cardiol 2003, 16:36-48.
11. Julkunen H., Kurki P., Kaaja R. Isolated congenital heart block long-term outcome of mothers and characterization of the immune response to SS-A/Ro and to SS-B/La. Arthritis Rheum 1993, 36:1588-1598.
12. Chameides L., Truex R.C., Vetter V., Rashkind W.J., Galioto F.M., Noonan J.A. Association of maternal systemic lupus erythematosus with congenital complete heart block. N Engl J Med 1977, 297:1204-1207.
13. Buyon J.P., Hiebert R., Copel J., Friedman D., Katholi M., Lee L.A., et al. Autoimmune-associated congenital heart block: demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry. J Am Coll Cardiol 1998, 31:1658-1666.
14. Eronen M., Sirèn M.K., Ekblad H., Tikanoja T., Julkunen H., Paavilainen T. Short- and long-term outcome of children with congenital complete heart block diagnosed in utero or as a newborn. Pediatrics 2000, 106:86-91.
15. Gordon P., Khamashta M., Hughes G.R., Rosenthal E., Simpson J., Sharland G. Early outcome in anti-Ro antibody associated congenital heart block. Arthritis Rheum 2001, 44:S161.
16. Jaeggi E.T., Hamilton R.M., Silverman E.D., Zamora S.A., Hornberger L.K. Outcome of children with fetal, neonatal or childhood diagnosis of isolated congenital atrioventricular block. A single institution's experience of 30years. J Am Coll Cardiol 2002, 39:130-137.
17. Izmirly P.M., Saxena A., Kim M.Y., Wang D., Sahl S.K., Llanos C., et al. Maternal and fetal factors associated with mortality and morbidity in a multi-racial/ethnic registry of anti-SSA/Ro-associated cardiac neonatal lupus. Circulation 2011, 124:1927-1935.
18. Ruffatti A., Marson P., Svaluto-Moreolo G., Marozio L., Tibaldi M., Favaro M., et al. A combination therapy protocol of plasmapheresis, intravenous immunoglobulins and betamethasone to treat anti-Ro/La-related congenital atrioventricular block. A case series and review of the literature. Autoimmun Rev 2013, 12:768-773.
19. Siamopoulou-Mavridou A., Manoussakis M.N., Mavridis A.K., Moutsopoulos H.M. Outcome of pregnancy in patients with autoimmune rheumatic disease before the disease onset. Ann Rheum Dis 1988, 47:982-987.
20. Julkunen H., Kaaja R., Kurki P., Palosuo T., Friman C. Fetal outcome in women with primary Sjögren's syndrome. A retrospective case-control study. Clin Exp Rheumatol 1995, 13:65-71.
21. Hussein S.Z., Jacobsson L.T., Lindquist P.G., Theander E. Pregnancy and fetal outcome in women with primary Sjogren's syndrome compared with women in the general population: a nested case-control study. Rheumatology (Oxford) 2011, 50:1612-1617.
22. Carvalheiras G., Faria R., Braga J., Vasconcelos C. Fetal outcome in autoimmune diseases. Autoimmun Rev 2012, 11:A520-A530.
23. Smyth A., Garovic V.D. Systemic lupus erythematosus and pregnancy. Minerva Urol Nefrol 2009, 61:457-474.
24. Kitridou R.C., Goodwin T.M. The fetus in systemic lupus erythematosus. Dubois' Lupus Erythematosus 2007, 1039-1057. Lippincott Williams & Wilkins. 7th ed. D.J. Wallace, B.H. Hahn (Eds.).
25. Gayed M., Gordon C. Pregnancy and rheumatic diseases. Rheumatology (Oxford) 2007, 46:1634-1640.
26. Miyakis S., Lockshin M.D., Atsumi T., Branch D.W., Brey R.L., Cervera R., et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006, 4:295-306.
27. Salmon J.E., de Groot P.G. Pathogenic role of antiphospholipid antibodies. Lupus 2008, 17:405-411.
28. Vashisht A., Regan L. Antiphospholipid syndrome in pregnancy-an update. J R Coll Physicians Edinb 2005, 35:337-339.
29. Ostensen M., Brucato A., Carp H., Chambers C., Dolhain R.J., Doria A., et al. Pregnancy and reproduction in autoimmune rheumatic diseases. Rheumatology (Oxford) 2011, 50:657-664.
30. Gasbarrini A., Torre E.S., Trivellini C., De Carolis S., Caruso A., Gasbarrini G. Recurrent spontaneous abortion and intrauterine fetal growth retardation as symptoms of coeliac disease. Lancet 2000, 356:399-400.
31. Vitali C., Bombardieri S., Jonsson R., Moutsopoulos H.M., Alexander E.L., Carsons S.E., et al. European Study Group on Classification Criteria for Sjögren's Syndrome. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002, 61:554-558.
32. Gagliardi L., Preve C.U., Di Montezemolo C.C., Mattone P.G., Piazza A. Intrauterine growth and gestational age in a sample of 9,774 cases. Ann Ostet Ginecol Med Perinat 1975, 96:147-158.
33. Skopouli F.N., Papanikolaou S., Malamou-Mits V., Papanikolaou N., Moutsopoulos H.M. Obstetric and gynaecological profile in patients with primary Sjögren's syndrome. Ann Rheum Dis 1994, 53:569-573.
34. Haga H.J., Gjesdal C.G., Koksvik H.S., Skomsvoll J.F., Irgens L.M., Ostensen M. Pregnancy outcome in patients with primary Sjögren's syndrome. a case-control study. J Rheumatol 2005, 32:1734-1736.
35. Takaya M., Ichikawa Y., Shimizu H., Uchiyama M., Moriuch J., Arimori S. Sjögren's syndrome and pregnancy. Tokai J Exp Clin Med 1991, 16(2):83-88.
36. Rai R., Regan L. Recurrent miscarriage. Lancet 2006, 368:601-611.
37. Priori R., Gattamelata A., Modesti M., Colafrancesco S., Frisenda S., Minniti A., et al. Outcome of pregnancy in Italian patients with primary Sjögren syndrome. J Rheumatol 2013, 40:1143-1147.